ClearPoint Neuro Q3 Loss Widens to $7.46 Million Despite 36.3% Revenue Growth

ClearPoint Neuro, Inc. (CLPT) reported a wider net loss of $7.46 million for its third quarter, or $0.24 per share, compared with a $5.89 million loss, or $0.21 per share, a year earlier. Revenue for the period rose 36.3% to $12.08 million from $8.86 million, the company said. The results are reported on a GAAP basis. The company guided full-year revenue to a range of $48.0 million to $50.0 million.